Skip to main content
. 2022 Aug 11;14(8):1756. doi: 10.3390/v14081756

Table 4.

Percentage of PCR-positive samples collected during experiments in whole trial periods.

Trial Number of Relevant Sampling Timepoints (Blood and Swabs) in Respective Trial Periods
(Trial Period)
Oral Swabs
—Positive (%)
Rectal Swabs—Positive (%) Blood—Positive
(%)
T1
(Arm07)
16
(0–8 dpi)
6/16 (37.5%) 6/16 (37.5%) 11/16 (68.8%)
T2
(Pol18)
43
(0–21 dpi)
13/43 (30.2%) 16/43 (37.2%) 24/43 (55.8%)
T3
(NH/P68)
63
(0–28 dpi)
4/63 (6.3%) 3/63 (4.8%) 7/63 (11.1%)